HK Stock Market Move | INNOGEN-B (02591) fell over 5% to reach a new low, with shareholders reducing their holdings by nearly 17 million Hong Kong dollars after the prohibition on sales expired.

INNOGEN-B (02591) fell over 5% during trading, reaching a low of HKD 4.22, setting a new historical low. As of the time of publication, it has dropped 4.57%, priced at HKD 4.28, with a transaction volume of HKD 27.1033 million. In terms of news, the latest data from the Hong Kong Stock Exchange shows that on August 17, Huang Li reduced his stake in Yuan Nuo Pharmaceutical by 3.35 million shares, totaling approximately HKD 16.8415 million. After the reduction, the latest number of shares held is about 40.6211 million, with a current holding ratio of 9.67%. It is reported that Yuan Nuo Pharmaceutical has been listed for over a year, and the 12-month lock-up commitment from the controlling shareholders and major shareholders expired on August 15. The number of shares released from the lock-up this time is 384 million shares, accounting for about 91.3% of the circulating shares.